» Articles » PMID: 37255405

Short-term Outcomes Between Robot-assisted and Open Pancreaticoduodenectomy in Patients with High Body Mass Index: A Propensity Score Matched Study

Overview
Journal Cancer Med
Specialty Oncology
Date 2023 May 31
PMID 37255405
Authors
Affiliations
Soon will be listed here.
Abstract

Background: High body mass index was considered as a risk factor for minimally invasive surgery. The short-term outcomes of robot-assisted pancreaticoduodenectomy (RPD) remain controversial. This study aims to investigate the feasibility and advantage of RPD in patients with high body mass index compared to open pancreaticoduodenectomy (OPD).

Methods: Clinical data of 304 patients who underwent pancreaticoduodenectomy from January 2016 to December 2019 in Ruijin Hospital, Shanghai Jiao Tong University School of Medicine was collected. Patients with BMI >25 kg/m were included and divided into RPD and OPD group. After PSM at a 1:1 ratio, 75 patients of OPD and 75 patients of RPD were recorded and analyzed.

Results: The RPD group showed advantages in the estimated blood loss (EBL) (323.3 mL vs. 480.7 mL, p = 0.010), the postoperative abdominal infection rate (24% vs. 44%, p = 0.010), the incidence of Clavien-Dindo III-V complications (14.7% vs. 28.0%, p = 0.042) over OPD group.

Conclusion: RPD shows advantages in less EBL, lower incidence rate of Clavien-Dindo III-V complications over OPD in overweight and obese patients. RPD was confirmed as a safe and feasible surgical approach for overweight or obsess patients.

Citing Articles

Comparing Operative Outcomes and Resection Quality in Robotic vs Open Pancreaticoduodenectomy: A Meta-analysis of 54,000 Patients.

Waseem M, Abideen Z, Durrani R, Dilawar E, Kamran M, Butt H J Gastrointest Cancer. 2025; 56(1):57.

PMID: 39875624 DOI: 10.1007/s12029-025-01177-0.


Impact of Obesity on Perioperative Outcomes in Robotic Pancreaticoduodenectomy: A Propensity Score-Matched Study.

Shyr B, Shyr B, Chen S, Wang S, Shyr Y Int J Med Robot. 2024; 20(6):e70034.

PMID: 39698987 PMC: 11656678. DOI: 10.1002/rcs.70034.


Comparison of short‑ and long‑term outcomes between laparoscopic and open pancreaticoduodenectomy in overweight patients: a propensity score‑matched study.

Xu S, Xu Y, Wang S, Chu Q, Zhang H, Gong W Surg Endosc. 2024; 39(2):881-890.

PMID: 39627557 DOI: 10.1007/s00464-024-11418-1.


Robotic pancreaticoduodenectomy in patients with overweight or obesity: a meta-analysis protocol.

Yang W, Zeng H, Jin Y BMJ Open. 2024; 14(7):e080605.

PMID: 39019640 PMC: 11284876. DOI: 10.1136/bmjopen-2023-080605.


Short-term outcomes between robot-assisted and open pancreaticoduodenectomy in patients with high body mass index: A propensity score matched study.

Li J, Qian L, Shi Y, Shen B, Peng C Cancer Med. 2023; 12(14):15141-15148.

PMID: 37255405 PMC: 10417296. DOI: 10.1002/cam4.6186.

References
1.
Afshin A, Forouzanfar M, Reitsma M, Sur P, Estep K, Lee A . Health Effects of Overweight and Obesity in 195 Countries over 25 Years. N Engl J Med. 2017; 377(1):13-27. PMC: 5477817. DOI: 10.1056/NEJMoa1614362. View

2.
Li S, Zhou K, Lai Y, Shen C, Wu Y, Che G . Estimated intraoperative blood loss correlates with postoperative cardiopulmonary complications and length of stay in patients undergoing video-assisted thoracoscopic lung cancer lobectomy: a retrospective cohort study. BMC Surg. 2018; 18(1):29. PMC: 5966911. DOI: 10.1186/s12893-018-0360-0. View

3.
Ball C, Pitt H, Kilbane M, Dixon E, Sutherland F, Lillemoe K . Peri-operative blood transfusion and operative time are quality indicators for pancreatoduodenectomy. HPB (Oxford). 2010; 12(7):465-71. PMC: 3030755. DOI: 10.1111/j.1477-2574.2010.00209.x. View

4.
Mullen J, Davenport D, Hutter M, Hosokawa P, Henderson W, Khuri S . Impact of body mass index on perioperative outcomes in patients undergoing major intra-abdominal cancer surgery. Ann Surg Oncol. 2008; 15(8):2164-72. DOI: 10.1245/s10434-008-9990-2. View

5.
Brawer R, Brisbon N, Plumb J . Obesity and cancer. Prim Care. 2009; 36(3):509-31. DOI: 10.1016/j.pop.2009.04.005. View